glp-1 obesity drug news today september 15 2025 Lilly hikes revenue forecasts on booming sales Oral GLP-1 Pill Delivers Injection-Like
Description
Manufacturers made false, misleading or incomplete representations of safety
doi: 10.1002/path.5056
Nauck MA, Vardarli I, Deacon CF, Holst JJ, Meier JJ
Using RNA sequencing of bone biopsies from patients treated with denosumab compared with placebo, the authors observed a down-regulation of skeletal DPP-4 expression with denosumab [3]
Trapp S, Brierley DI
Syringe selection: Use an insulin syringe with a 29 to 31 gauge needle
